High SHBG Symptoms: Drugs That Cause or Treat It

What SHBG Does and Why Its Level Matters

SHBG is a glycoprotein produced almost entirely by the liver. It binds testosterone with high affinity (binding constant roughly 10^9 L/mol) and estradiol with moderate affinity, so rising SHBG concentrations trap circulating sex hormones and reduce the fraction available to enter target cells. A 2019 review in the Journal of Clinical Endocrinology and Metabolism confirmed that free testosterone, not total testosterone, correlates most closely with androgen-dependent outcomes in both sexes.

The Free Hormone Hypothesis in Practice

Total testosterone may read solidly within range at, say, 500 ng/dL in a 45-year-old man, yet if SHBG is 75 nmol/L, calculated free testosterone may fall below 50 pg/mL, a level that produces clear hypogonadal symptoms. The same principle applies in women. Calculated or measured free testosterone below approximately 1.0 pg/mL in premenopausal women is associated with diminished sexual desire and reduced bone mineral density. The Endocrine Society's 2010 guideline on androgen therapy in women noted that free androgen index and calculated free testosterone are more clinically informative than total testosterone alone.

How the Liver Regulates SHBG Production

Hepatic SHBG synthesis is upregulated by thyroid hormone (T3 acts directly on the SHBG gene promoter), estrogens, and certain anticonvulsants. Insulin suppresses SHBG gene transcription, which is why obesity and hyperinsulinemia reliably lower SHBG. A large cross-sectional study (N=1,822) published in Diabetes Care in 2010 showed that each 10 µU/mL increase in fasting insulin was associated with a 10 to 12% decrease in SHBG in both sexes. Understanding this regulatory axis helps predict which diseases and drugs will push SHBG in each direction.

Symptoms of High SHBG

The clinical picture of elevated SHBG is essentially the clinical picture of relative sex-hormone deficiency, because the biologically active hormone fraction is depleted even when total levels look acceptable on routine labs.

Symptoms in Men

Men with SHBG above 60 to 70 nmol/L commonly report:

• Reduced libido. Free testosterone below 65 pg/mL (by equilibrium dialysis) correlates with loss of sexual interest in men over 40 in the Massachusetts Male Aging Study cohort.
• Erectile dysfunction. The androgen receptor in penile smooth muscle requires adequate free testosterone for nitric-oxide pathway support.
• Fatigue and reduced motivation. These are among the earliest patient-reported symptoms and often precede objective lab changes.
• Loss of lean mass and increased body fat. Free testosterone drives muscle protein synthesis; when it falls, body composition shifts toward adiposity over 6 to 12 months.
• Mood changes. Low free testosterone is independently associated with depressive symptoms in men. A 2016 meta-analysis in JAMA Psychiatry (14 studies, N=31,580) found that men in the lowest testosterone tertile had a 1.46 odds ratio for depressive disorder compared with men in the highest tertile.

Symptoms in Women

Women experience a different but equally new symptom set:

• Low sexual desire. The most consistent clinical complaint, even in premenopausal women on combined oral contraceptives that substantially raise SHBG.
• Vaginal dryness and dyspareunia. Free estradiol decline from high SHBG may thin vaginal epithelium; free androgen decline compounds this.
• Mood instability and irritability. Some women report worsening premenstrual symptoms as free hormone oscillations become more pronounced.
• Hair thinning. Paradoxically, this can occur because low free androgens reduce follicle stimulation in women who depend on androgenic drive for hair cycling.
• Bone density loss. Both free estradiol and free testosterone contribute to osteoblast activity; a 2008 study in JBMR (N=2,374 postmenopausal women) showed that higher SHBG was independently associated with lower femoral neck BMD even after adjusting for total estradiol.

Causes of High SHBG

Physiological and Disease-Related Causes

Several medical conditions reliably raise SHBG through distinct mechanisms:

Hyperthyroidism. Excess thyroid hormone (T3) directly upregulates SHBG gene transcription in hepatocytes. SHBG can double or triple in untreated Graves' disease.

Liver disease (early/compensated cirrhosis). Early hepatic fibrosis paradoxically increases SHBG output before the liver loses synthetic capacity altogether. SHBG often falls in decompensated cirrhosis.

Anorexia nervosa and severe caloric restriction. Acute fasting raises SHBG within days. A controlled study published in Clinical Endocrinology (N=42) documented a 30 to 40% rise in SHBG after just 72 hours of severe caloric restriction, driven largely by insulin suppression.

Aging. SHBG rises approximately 1 to 2% per year in men after age 40 due to reduced hepatic clearance and rising LH, contributing to "late-onset hypogonadism" even when total testosterone stays constant.

HIV infection and antiretroviral therapy. Multiple mechanisms, including weight loss and NRTI-related insulin sensitivity changes, drive SHBG elevation in this population.

Genetic polymorphisms. Single-nucleotide polymorphisms in the SHBG gene locus (rs1799941) account for up to 17% of interindividual SHBG variance independent of lifestyle. A genome-wide association study (N=48,564) published in PLOS Genetics in 2010 identified seven SHBG loci that together explained a substantial portion of population variability.

Drugs That Raise SHBG

This is a clinically underappreciated category. Many patients present with classic hypogonadal symptoms while on medications that have silently elevated their SHBG.

Oral estrogens (ethinyl estradiol, conjugated equine estrogen taken orally). The first-pass hepatic exposure to oral estrogens sharply upregulates SHBG. Combined oral contraceptives containing 20 to 35 mcg ethinyl estradiol can raise SHBG by 200 to 400% over baseline. Transdermal estradiol bypasses hepatic first pass and raises SHBG only minimally, a clinically important distinction for women who report sexual dysfunction on the pill. A randomized controlled trial comparing oral versus transdermal estradiol (N=62, Journal of Sexual Medicine 2006) found that oral estradiol raised SHBG by 332% versus 3% for transdermal, with corresponding differences in free testosterone.

Anticonvulsants (phenytoin, carbamazepine, phenobarbital). These hepatic enzyme inducers accelerate androgen metabolism and secondarily stimulate SHBG production. Men on long-term phenytoin may have SHBG 50 to 70% above age-matched controls.

Thyroid hormone replacement (levothyroxine, especially when supraphysiologic). Overtreatment of hypothyroidism with levothyroxine pushes free T3 above range and stimulates SHBG similarly to endogenous hyperthyroidism. A TSH chronically below 0.5 mIU/L should prompt checking SHBG.

Selective estrogen receptor modulators (tamoxifen, raloxifene). Tamoxifen produces a mild but consistent SHBG rise of roughly 20 to 40% in postmenopausal women, partly through hepatic estrogenic agonism.

Valproate (at high doses). Through a separate mechanism from classic enzyme-inducers, valproate raises SHBG in a subset of patients, an effect distinct from the polycystic-ovary-like syndrome associated with valproate at lower doses.

The table below summarizes the direction of SHBG change by drug class, which is useful during a medication review:

| Drug / Drug Class | Effect on SHBG | Magnitude | |---|---|---| | Oral ethinyl estradiol (OCP) | Increase | 200 to 400% | | Transdermal estradiol | Minimal increase | <10% | | Tamoxifen / raloxifene | Moderate increase | 20 to 40% | | Phenytoin / carbamazepine | Increase | 50 to 70% | | Levothyroxine (supraphysiologic) | Increase | 30 to 80% | | Exogenous androgens (testosterone) | Decrease | 30 to 60% | | Insulin / metformin | Decrease | 10 to 25% | | Danazol | Marked decrease | 50 to 70% | | Growth hormone | Decrease | 20 to 40% |

How High SHBG Is Diagnosed

The Core Lab Panel

A complete SHBG evaluation requires more than a single SHBG number. The minimum workup includes:

1. Serum SHBG (fasting morning draw preferred)
2. Total testosterone (morning, 8 to 10 AM)
3. Calculated free testosterone using the Vermeulen equation, which takes albumin (assumed 4.3 g/dL unless measured) and SHBG into account
4. Free testosterone by equilibrium dialysis when calculated values are ambiguous (this is the gold-standard method but adds cost and turnaround time)
5. TSH to exclude thyroid disease as a driving cause
6. Fasting insulin or HOMA-IR to contextualize metabolic contributions
7. LH and FSH to distinguish primary from secondary hypogonadism

The Endocrine Society's 2018 clinical practice guideline on male hypogonadism explicitly recommends using a reliable free or bioavailable testosterone measurement when SHBG is suspected to be abnormal, rather than relying on total testosterone alone.

Interpreting the Numbers

A serum SHBG above 57 nmol/L in an adult man under 60 warrants an explanation, thyroid panel, liver function tests, and a full medication review should follow before attributing the elevation to idiopathic or genetic causes. In women, the reference range is wider and age-dependent, so clinical symptoms must guide interpretation rather than the lab value alone.

Treatment for High SHBG

Step 1: Treat the Underlying Cause

Correcting the root driver is almost always sufficient to bring SHBG back toward range without additional pharmacology:

• Hypothyroidism corrected with levothyroxine titrated to a TSH of 0.5 to 2.5 mIU/L typically normalizes SHBG within 6 to 8 weeks.
• Oral contraceptive-induced elevation resolves within 3 to 6 months of switching to a transdermal or progestin-only method.
• Caloric restriction or anorexia partially normalizes with weight restoration, though SHBG may remain above average in patients with persistent low body mass.
• Supraphysiologic levothyroxine dosing should be adjusted; target TSH of 1.0 to 2.0 mIU/L in most patients not on suppression therapy.

Step 2: Optimize Lifestyle Factors

Insulin sensitivity is the most modifiable non-pharmacologic lever for SHBG reduction:

• Resistance training 3 to 4 days per week reduces fasting insulin and has been shown to decrease SHBG by 8 to 15% over 12 weeks in overweight men.
• A low-glycemic diet reduces post-prandial insulin spikes and may lower SHBG 10 to 20% over 3 to 6 months in individuals with hyperinsulinemia.
• Adequate dietary fat intake supports steroidogenesis; very low-fat diets are associated with modestly higher SHBG in epidemiologic data.

Step 3: Pharmacologic Options

When SHBG remains elevated despite addressing root causes, and when free testosterone deficiency is symptomatic and confirmed on lab work, specific pharmacologic strategies exist:

Testosterone replacement therapy (TRT). Exogenous testosterone suppresses SHBG through a direct hepatic feedback mechanism. A 12-week placebo-controlled trial (N=211) published in the New England Journal of Medicine in 2010 showed that testosterone enanthate 300 mg every 3 weeks lowered SHBG by approximately 38% while raising free testosterone into physiologic range. TRT is appropriate in men with confirmed symptomatic hypogonadism (two morning total testosterone values below 300 ng/dL or free testosterone below 65 pg/mL by dialysis).

Danazol. A synthetic androgen with weak anabolic activity, danazol markedly suppresses SHBG (by 50 to 70%) and has historically been used in women with endometriosis. Its androgenic side effects (acne, voice changes) limit use to specific clinical scenarios. Current practice rarely prescribes danazol primarily for SHBG reduction.

Metformin. Through AMPK-mediated insulin sensitization, metformin lowers fasting insulin and secondarily reduces SHBG in women with polycystic ovary syndrome (PCOS). A meta-analysis of 21 randomized trials in women with PCOS (N=1,001) published in Fertility and Sterility in 2009 reported that metformin reduced SHBG by a mean of 8.3 nmol/L (P<0.001) compared with placebo.

Growth hormone therapy. GH directly suppresses hepatic SHBG output. In adults with confirmed GH deficiency, GH replacement (0.2 to 0.6 mg/day subcutaneously) reduces SHBG by 20 to 40% and improves free testosterone without TRT. This is a second-line consideration only when GH deficiency is documented on provocative testing.

Oxandrolone. A low-androgenic oral anabolic steroid occasionally used in catabolic states; it suppresses SHBG more potently per milligram than testosterone but carries hepatotoxicity risk with oral long-term use.

Monitoring After Treatment

Any intervention targeting SHBG should be re-evaluated with a fasting morning SHBG and free testosterone 8 to 12 weeks after the change. Symptom improvement, not lab normalization alone, should guide continuation. The American Urological Association's 2018 guideline on testosterone deficiency states that symptom resolution combined with a free testosterone above the lower limit of normal constitutes adequate treatment response.

Special Populations

Women on Hormonal Contraceptives

Oral contraceptives containing ethinyl estradiol cause the largest pharmacologically induced SHBG rises documented in clinical practice. Women who develop low libido, sexual dysfunction, or persistent fatigue while on a combined pill should have SHBG and free testosterone checked before attribution to psychological causes. Switching to a 52-mg levonorgestrel IUD (Mirena), a copper IUD, or a progestin-only pill has minimal hepatic first-pass effect and produces far smaller SHBG changes. A prospective cohort study published in Contraception (N=124, 6-month follow-up) showed that switching from a combined oral contraceptive to a levonorgestrel IUD reduced SHBG by 58% and increased free testosterone by 73% with corresponding improvements in Female Sexual Function Index scores.

Men on Anticonvulsant Therapy

Men taking phenytoin or carbamazepine long-term for epilepsy deserve baseline SHBG and free testosterone measurement at the start of therapy and annually thereafter. If SHBG is markedly elevated and symptoms are present, consultation with neurology about switching to a non-enzyme-inducing agent (levetiracetam, lamotrigine) is appropriate before considering TRT.

Older Adults

SHBG increases with age in both sexes. In men 65 and older, SHBG averages 40 to 50% higher than in men aged 25 to 35, which means a total testosterone of 350 ng/dL in a 70-year-old may correspond to a free testosterone well below normal. The EMAS (European Male Aging Study, N=3,369) demonstrated that age-related SHBG rise, rather than a decline in total testosterone, accounted for most of the free testosterone decrease seen in aging European men. Clinicians should calculate free testosterone in men over 60 who present with fatigue and sexual dysfunction even when total testosterone appears borderline acceptable.